Analysis of the efficacy and safety of bortezomib for treating newly diagnosed multiple myeloma through different administration methods

Background This study aims to compare the efficacy and adverse reactions of bortezomib for treating newly diagnosed multiple myeloma (MM) through two different administration methods: intravenous (IV) injection and subcutaneous (SC) injection.